Browse All
Displaying 1 - 3 of 3
Author:Williams, Mitzi Airas, Laura Chitnis, Tanuja Saini, Sarbjit Hide, Michihiro Sussman, Gordon Nakahara, Jin Bermel, Robert Dörner, Thomas Loop, Brett Ziehn, Marina Willi, Roman Kieseier, Bernd C. Nikolaev, Ivan Haemmerle, Sibylle Zharkov, Artem Siegel, Richard Cenni, Bruno Wiendl, Heinz Maurer, Marcus Giménez-Arnau, Ana Montalban, Xavier
Session Name:P7: MS Therapeutics 1
Topic:MS and Inflammatory Disease
Program Number:P7.015
Author Institution:Joi Life Wellness Group, Atlanta, GA, USA, Atlanta, GA Turku University Hospital and University, Finland, Turku, Finland Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA, Boston, MA Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA, Baltimore, MD Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, Hiroshima, Japan University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin DRFZ, Berlin, Germany, Berlin, Germany Novartis Pharmaceutical Corporation, Cambridge, MA, USA, Cambridge, MA Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Novartis Pharma AG, Basel, Switzerland Department of Neurology, Heinrich-Heine University, Duesseldorf, Germany, Duesseldorf, Germany Novartis Institutes for Biomedical Research, Basel, Switzerland, Basel, Switzerland Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, Muenster, Germany Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, Berlin, Germany Department of Dermatology, Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain, Barcelona, Spain Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain
Author:Nylund, Marjo Matilainen, Markus Sucksdorff, Marcus Polvinen, Eero Airas, Laura
Session Name:P11: MS Neuroimaging 2
Program Number:P11.011
Author Institution:Turku University Hospital, Turku, Finland University of Turku, Helsinki, Finland
Author:Bagnato, Francesca Scalfari, Antonio Oh, Jiwon Airas, Laura Bittner, Stefan Calabrese, Massimiliano Garcia Dominguez, Jose Manuel Granziera, Cristina Greenberg, Benjamin Hellwig, Kerstin Illes, Zsolt Laszlo Lycke, Jan Traboulsee, Anthony Popescu, Veronica Giovannoni, Gavin
Program Number:P11.013
Author Institution:Vanderbilt University Medical Center, Nashville, TN Imperial college, London, United Kingdom St Michael's Hospital, Toronto, ON, Canada University of Turku, Turku, Finland Johannes Gutenberg- University, Mainz, Germany Clinica Neurologica I, Padova, Italy Hospital General Universitario Gregorio Marañón, Madrid, Spain Basel University Hospital, Basel, Switzerland UT Southwestern, Dallas, TX St. Josef Hospital Bochum, Bochum, Germany Odense University Hospital, Odense, Denmark University of Gothenburg, Gothenburg, Sweden University of British Columbia, Vancouver, BC, Canada Noorderhart Hospital, Pelt, Belgium QMUL, London, United Kingdom
